The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Plaque Calcification During Atherosclerosis Progression and Regression
Open accessAbstract
Plaque calcification develops by the inflammation-dependent mechanisms involved in progression and regression of atherosclerosis. Macrophages can undergo two distinct polarization states, that is, pro-inflammatory M1 phenotype in progression and anti-inflammatory M2 phenotype in regression. In plaque progression, predominant M1 macrophages promote the initial calcium deposition within the necrotic core of the lesions, called as microcalcification, through not only vesicle-mediated mineralization as the result of apoptosis of macrophages and vascular smooth muscle cells (VSMCs), but also VSMC differentiation into early phase osteoblasts. On the other hand, in plaque regression M2 macrophages are engaged in the healing response to plaque inflammation. In association with the resolution of chronic inflammation, M2 macrophages may facilitate macroscopic calcium deposition, called as macrocalcification, through induction of osteoblastic differentiation and maturation of VSMCs. Oncostatin M, which has been shown to promote osteoblast differentiation in bone, may play a pivotal role in the development of plaque calcification. Clinically, two types of plaque calcification have distinct implications. Macrocalcification leads to plaque stability, while microcalcification is more likely to be associated with plaque rupture. Statin therapy, which reduces cardiovascular mortality, has been shown to exert its dual actions on plaque morphology, that is, regression of atheroma and increment of macroscopic calcium deposits. Statins may facilitate the healing process against plaque inflammation by enhancing M2 polarization of macrophages. Vascular calcification has pleiotropic properties as pro-inflammatory "microcalcification" and anti-inflammatory "macrocalcification". The molecular mechanisms of this process in relation with plaque progression as well as plaque regression should be intensively elucidated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nissen, S. E., Nicholls, S. J., Sipahi, I., Libby, P., Raichlen, J. S., Ballantyne, C. M., Davignon, J., Erbel, R., Fruchart, J. C., Tardif, J.-C., et al. (2006) · JAMA · doi:10.1001/jama.295.13.jpc60002 · Cited by 2,047
Tearney, G. J., Regar, E., Akasaka, T., Adriaenssens, T., Barlis, P., Bezerra, H. G., Bouma, B., Bruining, N., Cho, J.-M., Chowdhary, S., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.079 · Cited by 1,874
Joshi, N. V., Vesey, A. T., Williams, M. C., Shah, A. S. V., Calvert, P. A., Craighead, F. H. M., Yeoh, S. E., Wallace, W., Salter, D., Fletcher, A. M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61754-7 · Cited by 953
Effect of Two Intensive Statin Regimens on Progression of Coronary Disease
Nicholls, S. J., Ballantyne, C. M., Barter, P. J., Chapman, M. J., Erbel, R. M., Libby, P., Raichlen, J. S., Uno, K., Borgman, M., Wolski, K., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1110874 · Cited by 890
Prati, F., Regar, E., Mintz, G. S., Arbustini, E., Di Mario, C., Jang, I.-K., Akasaka, T., Costa, M., Guagliumi, G., Grube, E., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp433 · Cited by 880
Vascular Calcification: Mechanisms and Clinical Ramifications
Abedin, M., Tintut, Y., & Demer, L. L. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000133194.94939.42 · Cited by 863
New insights into the multidimensional concept of macrophage ontogeny, activation and function
Ginhoux, F., Schultze, J. L., Murray, P. J., Ochando, J., & Biswas, S. K. (2016) · Nature Immunology · doi:10.1038/ni.3324 · Cited by 833
Aikawa, E., Nahrendorf, M., Figueiredo, J.-L., Swirski, F. K., Shtatland, T., Kohler, R. H., Jaffer, F. A., Aikawa, M., & Weissleder, R. (2007) · Circulation · doi:10.1161/circulationaha.107.732867 · Cited by 698
Calcium Density of Coronary Artery Plaque and Risk of Incident Cardiovascular Events
Criqui, M. H., Denenberg, J. O., Ix, J. H., McClelland, R. L., Wassel, C. L., Rifkin, D. E., Carr, J. J., Budoff, M. J., & Allison, M. A. (2014) · JAMA · doi:10.1001/jama.2013.282535 · Cited by 642
Distribution of macrophage polarization markers in human atherosclerosis
Stöger, J. L., Gijbels, M. J. J., van der Velden, S., Manca, M., van der Loos, C. M., Biessen, E. A. L., Daemen, M. J. A. P., Lutgens, E., & de Winther, M. P. J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.09.013 · Cited by 621
Cited by
Randall’s plaque and calcium oxalate stone formation: role for immunity and inflammation
Khan, S. R., Canales, B. K., & Dominguez-Gutierrez, P. R. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00392-1 · Cited by 423
Atherosclerotic Plaque Healing
Vergallo, R., & Crea, F. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2000317 · Cited by 379
Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Chen, R., Zhang, H., Tang, B., Luo, Y., Yang, Y., Zhong, X., Chen, S., Xu, X., Huang, S., & Liu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01840-1 · Cited by 349
Atherosclerotic Carotid Plaque Composition and Incident Stroke and Coronary Events
Bos, D., Arshi, B., van den Bouwhuijsen, Q. J. A., Ikram, M. K., Selwaness, M., Vernooij, M. W., Kavousi, M., & van der Lugt, A. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.01.038 · Cited by 277
Effect of statins on atherosclerotic plaque
Almeida, S. O., & Budoff, M. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.01.001 · Cited by 263
Metadata
- Authors
- Shioi, A., & Ikari, Y.
- Venue
- Journal of Atherosclerosis and Thrombosis
- Publisher
- Japan Atherosclerosis Society
- Published
- 2018
- Volume
- 25
- Issue
- 4
- Pages
- 294-303
- ISSN
- 1340-3478 (ISSN-L)
- 1880-3873
- OpenAlex
- W2773133015
- Cited by
- 271
- References
- 63
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plaque Calcification During Atherosclerosis Progression and Regression. https://app.cochat.ai/papers/10.5551/jat.rv17020
- The paper
- Shioi, A., & Ikari, Y. (2018). Plaque Calcification During Atherosclerosis Progression and Regression. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.rv17020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.